Autopsy report · NCT01813955

Phosphodiesterase (PDE) Inhibitors Effect on Cognitive Deficits Associated to Schizophrenia

“Patient recruitment insufficient”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months after it had already started.
• Ran for about 2 years before it stopped.
• 5 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Early Phase 1

Sponsor

University of Copenhagen

Sponsor type

University, hospital or other

Conditions

Schizophrenia; Cognitive Deficits

Interventions

Papaverine or placebo

Participants

5

Sites

1

Countries

Denmark

Trials that died the same way

• Daptomycin in Pediatric Patients With Bacterial Meningitis
  “Insufficient patient recruitment” (98% match in meaning)
• Fesoterodine on Urgency Episodes in Parkinson's Disease Population
  “Insufficient or untimely patient recruitment” (95% match in meaning)
• Near Infrared Spectroscopy in Patients Undergoing Robotic Assisted Laparoscopic Surgery in the Trendelenburg Position
  “No sufficient patient recruitment” (93% match in meaning)
• Macular Edema Incidence/Severity Reduction With Nevanac
  “Patient recruitment difficulties” (93% match in meaning)
• Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7)
  “Difficulties in patient recruitment” (93% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.